• Healius has entered into a national agreement framework with Ramsay Health Care subsidiaries
• Transition effective from 1 July 2026
• No change in pathology services at thirteen hospitals
• New agreements expected to generate approximately $45m in annual revenue

Healius Limited (ASX: HLS) has announced a national agreement framework with wholly-owned subsidiaries of Ramsay Health Care Limited (ASX:RHC), effective from 1 July 2026. This transition will unify existing pathology leases and service arrangements into a single framework without altering the services provided at thirteen hospitals across New South Wales, Western Australia, Victoria, and Queensland. The new agreements are expected to generate approximately $45 million in annual revenue, based on consistent customer demand and economic conditions. Healius remains the incumbent provider of pathology services for both public and private patients.

Total annual revenue under the initial terms of the new agreements is expected to be approximately $45m.

Healius expects the new national framework to deliver consistent, quality pathology services to meet the needs of Ramsay hospital practitioners and patients.